Bupropion is not considered addictive when taken as prescribed. It is not classified as a controlled substance by the DEA, and it does not produce the intense euphoria or compulsive drug-seeking behavior associated with addictive stimulants. That said, the picture is more nuanced than a simple “no.” Bupropion does act on some of the same brain chemicals that addictive drugs target, and misuse through non-oral routes has been documented, particularly in correctional and substance use treatment settings.
How Bupropion Affects the Brain
Bupropion works by blocking the reuptake of two neurotransmitters: dopamine and norepinephrine. This is the same basic mechanism that makes cocaine and methamphetamine stimulating. The critical difference is degree. At standard therapeutic doses (150 mg twice daily), bupropion occupies only about 25% of dopamine transporters in the brain. Addictive stimulants flood the dopamine system far more aggressively, often occupying 60% or more of those same transporters to produce an intense high.
That modest 25% occupancy is enough to lift mood and improve focus without producing the rush of euphoria that drives compulsive use. Brain concentrations of bupropion and its breakdown products stay above the threshold needed to affect dopamine and norepinephrine throughout the typical 12-hour dosing window, which creates a steady, low-level effect rather than sharp peaks and crashes. This pharmacological profile is a major reason bupropion has a low addiction risk when swallowed in pill form as directed.
Why It’s Not a Controlled Substance
The DEA does not schedule bupropion, meaning it carries no special prescribing restrictions like those placed on stimulants such as Adderall or Ritalin. Human studies on “drug liking,” where participants rate how much they enjoy a substance’s effects, have produced mixed results for bupropion. Some studies show subjective effects that overlap slightly with mild stimulants like methylphenidate, while others find little noticeable difference from placebo. Animal studies paint a somewhat more concerning picture: rodents and primates will self-administer bupropion in patterns similar to cocaine. But in real-world clinical use, bupropion has not generated the patterns of escalating doses, cravings, and compulsive use that define addiction.
Misuse Does Happen
Despite its low addiction risk when taken orally, bupropion has a documented history of misuse, especially through nasal insufflation (snorting crushed tablets) and, less commonly, intravenous injection. Snorting bupropion bypasses the slow absorption of the gut and avoids the liver’s first-pass metabolism, delivering the drug to the brain much faster. Users who misuse it this way report a brief euphoria, increased energy, and a “high” that oral dosing does not produce.
This type of misuse carries serious risks. The most dangerous is seizures, which are dose-dependent. At normal oral doses of 300 mg per day, the seizure risk is about 0.1%. In overdose, seizures occur in roughly a third of cases with immediate-release formulations, and patients who take more than 15 tablets become highly vulnerable. One published case involved a man in his fifties with long-term bupropion misuse via snorting who was hospitalized after insufflating 2,100 mg. He suffered a heart attack triggered by the overdose and died about two weeks after discharge. Beyond seizures, overdose can cause rapid heart rate, dangerous changes in heart rhythm, confusion, hallucinations, and coma.
Reports of bupropion misuse have increased in correctional facilities and inpatient treatment programs, where access to other drugs is limited. In these environments, bupropion tablets have sometimes been referred to by slang names and traded among residents.
Bupropion Actually Treats Addiction
One of bupropion’s most established uses is helping people quit smoking. It works partly by blocking nicotine receptors in the brain’s reward center. At clinical concentrations, bupropion inhibits 75 to 95% of nicotine’s stimulatory effects on dopamine neurons. This blunts the pleasurable hit from cigarettes without eliminating it entirely, making it easier to resist cravings. At the same time, bupropion mildly boosts baseline dopamine levels on its own, which can help offset the low mood and irritability that often accompany nicotine withdrawal.
Bupropion has also shown promise for stimulant use disorders. Research found that bupropion treatment reduced the subjective “high” from methamphetamine and dampened cue-induced craving. Clinical guidelines from the American Society of Addiction Medicine suggest that bupropion may be considered for patients with cocaine use disorder to support abstinence, and for those with amphetamine-type stimulant use disorder who use stimulants fewer than 18 days per month. It is also recommended as an option for people with co-occurring depression or tobacco dependence alongside a stimulant use disorder.
What Happens When You Stop Taking It
Bupropion can cause discontinuation symptoms if stopped abruptly, though this is less common and generally milder than withdrawal from SSRIs or SNRIs. In one documented case, a 32-year-old man who had been taking bupropion for eight weeks inadvertently stopped the medication. About five days later, he developed irritability, anxiety, insomnia, headache, and generalized body aches. His symptoms resolved within 36 hours of restarting the medication.
Discontinuation symptoms are not the same as addiction. They reflect the brain readjusting to the absence of a drug it had adapted to, which can happen with many non-addictive medications, including blood pressure drugs and certain antidepressants. Tapering gradually rather than stopping suddenly reduces the likelihood of these effects.
Who Should Be Cautious
Bupropion lowers the seizure threshold, so it is contraindicated in people with seizure disorders, those withdrawing from alcohol or sedatives, and individuals with a history of eating disorders like bulimia or anorexia nervosa (which independently increase seizure risk). Staying within the prescribed dose is important: the seizure risk climbs sharply at higher amounts, and there is no safe way to use bupropion through non-oral routes.
For the vast majority of people taking bupropion as prescribed for depression, seasonal affective disorder, or smoking cessation, the risk of developing an addiction to the medication itself is very low. The concern centers almost entirely on non-oral misuse at high doses, a pattern that looks nothing like typical outpatient use.